RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,627,280 | +41.0% | 15,506,834 | +37.7% | 0.00% | +50.0% |
| Q2 2023 | $84,110,946 | +15.3% | 11,259,832 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $72,927,005 | -6.0% | 10,933,584 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $77,542,269 | -13.0% | 10,057,363 | +20.0% | 0.00% | -33.3% |
| Q3 2022 | $89,174,000 | +56.8% | 8,380,986 | +19.9% | 0.00% | +50.0% |
| Q2 2022 | $56,879,000 | +20.2% | 6,987,467 | +5.7% | 0.00% | +100.0% |
| Q1 2022 | $47,338,000 | -54.8% | 6,611,377 | +8.1% | 0.00% | -50.0% |
| Q4 2021 | $104,731,000 | +67.8% | 6,113,873 | +125.4% | 0.00% | 0.0% |
| Q3 2021 | $62,403,000 | -36.3% | 2,711,980 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $97,934,000 | – | 2,683,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |